CAVACURMIN
LIVE

Serial Number

79176088

Owner

WACKER CHEMIE AG

Attorney

Victoria Friedman

Filing Date

Sep 3, 2015

Add to watchlist:

No watchlists yet
View on USPTO

CAVACURMIN Trademark

Serial Number: 79176088 • Registration: 5445399

CAVACURMIN is a trademark filed by WACKER CHEMIE AG on September 3, 2015. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 29 (Meats & Processed Foods), Class 30 (Staple Foods). The application is currently registered and active.

Owner Contact Info

WACKER CHEMIE AG (125 trademarks)

HANNS-SEIDEL-PLATZ 4
MUNICH 81737 , DE

Entity Type: 09

Trademark Details

Filing Date

September 3, 2015

Registration Date

April 17, 2018

Published for Opposition

July 11, 2017

Goods & Services

Chemicals for industrial [ , scientific, agricultural and forestry ] purposes, namely, chemicals for use in the [ chemical, plastics, metallurgical, glass, paper, ceramics, photography, agricultural, horticultural, forestry, commercial and residential building, construction, automobile, automotive, insulation, packaging, engineering, energy, electronics, ] pharmaceutical, [ cosmetic, fragrance, textile, leather, synthetic rubber, ] healthcare, personal care, food, [ paint, mould making, semi-conductor, microchip and terrestrial photovoltaic ] industries, and biochemical and biotechnological products for industrial, [ scientific, agricultural and forestry ] purposes, namely, chemicals for use in biotechnological product development and biotechnological manufacturing processes; oligosaccharides and polysaccharides and derivatives thereof being unprocessed oligomers and polymers for industrial purposes; cyclodextrins and cyclodextrin derivatives for industrial use; chemical compositions containing cyclodextrins and cyclodextrin derivatives, either alone or in combination, for general purpose in the cosmetic, healthcare, pharmaceutical, personal care, food and beverage industries; [ chemical solutions, dispersions and emulsions containing cyclodextrins and cyclodextrin derivatives, either alone or in combination, for use in the manufacture of a wide variety of goods; ] raw materials being antioxidants, [ phenols, vitamins, essential oils, phytochemicals, fats, proteins and carbohydrates ] in raw material form, active substances being active chemical ingredients for use in the manufacture of medical and pharmaceutical preparations; [ enzymes for industrial purposes and enzyme preparations for general industrial use in the cosmetic, healthcare, pharmaceutical, personal care, food and beverage industry; enzymes and enzyme preparations for the food industry; ] cyclodextrins and derivatives thereof for foodstuffs and dietetic foodstuffs and in [ the form of process aids for the food industry and the dietetic food industry; ] raw materials being antioxidants, [ phenols, vitamins, essential oils, phytochemicals, fats, proteins and carbohydrates ] in raw material form, active substances being active chemical ingredients for foodstuffs and beverages; cyclodextrins and cyclodextrin derivatives for use in the manufacture of foodstuffs and beverages and dietary food supplements; [ phenols and derivatives thereof for industrial purposes; ] antioxidants for use in manufacture of a wide variety of goods; all of the aforementioned goods with the exception of diagnostic preparations for scientific use

[ Foodstuffs based on cyclodextrins and cyclodextrin derivatives, namely, spices, processed herbs, processed grains, products derived from cereals, namely, processed cereals, cereal bars and cereal-based snack food; dietetic additives for foodstuffs, namely, flavor enhancers used in food and beverage products, natural sweeteners, thickening agents for use in cooking, spices, processed herbs all for culinary purposes not for industrial use; cyclodextrins and cyclodextrin derivatives in the form of fibres for making foodstuffs, namely, food additives containing cyclodextrins and cyclodextrin derivatives for culinary purposes, not for industrial use; dietetic foodstuffs based on cyclodextrins and cyclodextrin derivatives for culinary purposes, not for medical and industrial purposes, namely, spices, processed herbs, processed grains, products derived from cereals, namely, processed cereals, cereal bars and cereal-based snack food; dietetic foodstuffs, not for medical purposes, based on carbohydrates, namely, spices, processed herbs, processed grains, products derived from cereals, namely, processed cereals, cereal bars and cereal-based snack food; edible ices; sugar, honey, treacle ]

Pharmaceutical preparations, namely, oligosaccharides and polysaccharides and derivatives thereof used as auxiliaries and additives and as carriers, all being an integral component in pharmaceutical preparations for treatment of infectious diseases, injuries, degenerative conditions, tumor, mental illnesses, psychosomatic illnesses, diseases of civilization, namely, venereal diseases, cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, nervous system diseases, viral diseases, diabetes, cancer, AIDS and infectious diseases, immune and autoimmune diseases, inflammatory diseases, obesity, deficiencies, namely, nutritional, cancer and inborn, vitamin, and immunological deficiencies, scars, wounds, pain, ophthalmic diseases and conditions, [ for use in the replacement or supplement of body parts with defects caused by trauma and disease or by birth and in the replacement or supplement of body parts lost by trauma, disease or missing from birth ] as well as and in veterinary preparations, namely, pain relief medication, antioxidants and preparations for treatment of intestinal bacteria; cyclodextrins and cyclodextrin derivatives in the form of nutritional food additives for medicines, human foodstuffs and foodstuffs for animals in the nature of processed food extracts derived from plants; [ biocides; ] cyclodextrins and derivatives thereof being chemical preparations for pharmaceutical and veterinary purposes, and medicinal healthcare preparations featuring cyclodextrins and derivatives thereof for the prevention and treatment of infectious diseases, injuries, degenerative conditions, tumor, mental illnesses, psychosomatic illnesses, diseases of civilization, namely, venereal diseases, cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, nervous system diseases, viral diseases, diabetes, cancer, AIDS and infectious diseases, immune and autoimmune diseases, inflammatory diseases, deficiencies, namely, nutritional, cancer and inborn, vitamin, and immunological deficiencies, scars, wounds, pain, ophthalmic diseases and conditions, [ for use in the replacement or supplement of body parts with defects caused by trauma and disease or by birth and in the replacement or supplement of body parts lost by trauma, disease or missing from birth ] as well as and in veterinary preparations, namely, pain relief medication, antioxidants and preparations for treatment of intestinal bacteria; [ complexed oils for dietetic purposes, namely, essential oils; complexed oils for making food for babies, namely, essential oils; complexed oil extracts for dietetic purposes in the form of dieting powder preparations to promote weight loss; ] dietetic foodstuffs, namely, spices, herbs [ , meat, fish, seafood, eggs, egg products, milk, dairy products, fruits, vegetables, nuts, grains, baby food, pet food, drinks, ] and dietary food supplements for medical purposes; cyclodextrins and cyclodextrin derivatives being chemical preparations for dietetic purposes; [ chemical preparations containing phenols and derivatives thereof for medical and veterinary purposes, namely, for treatment of infectious diseases, injuries, degenerative conditions, tumor, mental illnesses, psychosomatic illnesses, diseases of civilization, namely, venereal diseases, cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, nervous system diseases, viral diseases, diabetes, cancer, AIDS and infectious diseases, immune and autoimmune diseases, inflammatory diseases, obesity, deficiencies, namely, nutritional, cancer and inborn, vitamin, and immunological deficiencies, scars, wounds, pain, ophthalmic diseases and conditions, for use in the replacement or supplement of body parts with defects caused by trauma and disease or by birth and in the replacement or supplement of body parts lost by trauma, disease or missing from birth; ] chemical preparations containing antioxidants for medical and veterinary purposes, namely, for treatment of infectious diseases, injuries, degenerative conditions, tumor, mental illnesses, psychosomatic illnesses, diseases of civilization, namely, venereal diseases, cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, nervous system diseases, viral diseases, diabetes, cancer, AIDS and infectious diseases, immune and autoimmune diseases, inflammatory diseases, obesity, deficiencies, namely, nutritional, cancer and inborn, vitamin, and immunological deficiencies, scars, wounds, pain, ophthalmic diseases and conditions [ , for use in the replacement or supplement of body parts with defects caused by trauma and disease or by birth and in the replacement or supplement of body parts lost by trauma, disease or missing from birth; ] dietary supplements containing antioxidants for medical and veterinary purposes; dietary supplements; [ dietary supplements containing phenols and derivatives thereof; ] dietary supplements containing antioxidants; [ dietary supplements containing complexed oils or fats, not for medical purposes; ] dietary supplements containing cyclodextrins and cyclodextrin derivatives, not for medical purposes; all of the aforementioned goods with the exception of vaccines, antibiotics, diagnostic preparations for therapeutic, medical and veterinary use, chemical reagents for therapeutic, medical, pharmaceutical and veterinary use, bacteriological preparations for medical or veterinary use

[ Foodstuff processing modification, namely, modification of foodstuffs with nutritional food additives; food processing treatment of foodstuffs, namely, treating of foodstuffs with nutritional food additives; processing of foodstuffs for food production; food preservation; food smoking ]

[ Dietetic foodstuffs based on complexed oils or fats, not for medical purposes, namely, spices, herbs, meat, processed fish, processed seafood, eggs, egg substitute products, milk, processed fruits, processed vegetables, processed nuts, edible fats, edible oils, preparations for making soup, soy milk, milk of almonds for culinary purposes, rice milk, drinks based on yoghurt, drinks based on milk; dietetic foodstuffs, not for medical purposes, based on proteins, fats, albumen containing phenols or derivatives thereof, and antioxidants, namely, meat, processed fish, processed seafood, eggs, egg substitute products, milk, processed fruits, processed vegetables, processed nuts; preserved, frozen, dried and cooked fruits and vegetables ]

Filing History

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Jan 13, 2026 INNA
PARTIAL INVALIDATION PROCESSED BY THE IB
Oct 10, 2025 INNP
CORRECTION TRANSACTION RECEIVED FROM IB
Oct 10, 2025 CRCV
INTERNATIONAL REGISTRATION RENEWED
Sep 4, 2025 RNWL
GENERIC MADRID TRANSACTION SENT TO IB
Jul 22, 2025 XXSS
GENERIC MADRID TRANSACTION CREATED
Jul 21, 2025 XXCR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jul 21, 2025 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Nov 21, 2024 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Nov 21, 2024 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 13, 2024 APRE
CHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 6, 2024 ADCH
TEAS SECTION 71 & 15 RECEIVED
Mar 22, 2024 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 17, 2023 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 31, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 3, 2018 FICS
FINAL DISPOSITION PROCESSED
Aug 3, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 17, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 17, 2018 R.PR
TTAB RELEASE CASE TO TRADEMARKS
Mar 14, 2018 TMBN
OPPOSITION TERMINATED NO. 999999
Mar 14, 2018 OP.T
OPPOSITION DISMISSED NO. 999999
Mar 14, 2018 OP.D
NOTIFICATION PROCESSED BY IB
Oct 28, 2017 GPNX
REFUSAL PROCESSED BY IB
Sep 29, 2017 RFNT
OPPOSITION INSTITUTED NO. 999999
Sep 20, 2017 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Sep 11, 2017 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Sep 9, 2017 OPNC
EXTENSION OF TIME TO OPPOSE RECEIVED
Aug 10, 2017 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 11, 2017 NPUB
PUBLISHED FOR OPPOSITION
Jul 11, 2017 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 21, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 21, 2017 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 21, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 5, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 18, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
May 17, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 17, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
May 17, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 17, 2017 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 15, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 15, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 12, 2017 TROA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 28, 2017 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 12, 2017 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 12, 2017 OPNR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 6, 2016 GNRN
NON-FINAL ACTION E-MAILED
Dec 6, 2016 GNRT
NON-FINAL ACTION WRITTEN
Dec 6, 2016 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 7, 2016 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 27, 2016 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 27, 2016 GNSL
SUSPENSION LETTER WRITTEN
Apr 27, 2016 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 30, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 30, 2016 CRFA
ASSIGNED TO LIE
Mar 29, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 16, 2016 TROA
REFUSAL PROCESSED BY IB
Jan 22, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 6, 2016 RFCS
REFUSAL PROCESSED BY MPU
Jan 6, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 30, 2015 RFCR
NON-FINAL ACTION WRITTEN
Dec 29, 2015 CNRT
ASSIGNED TO EXAMINER
Dec 16, 2015 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 20, 2015 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 16, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 15, 2015 REPR